The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 30, 2021

Filed:

Feb. 22, 2018
Applicant:

West Affum Holdings Corp., Grand Cayman, KY;

Inventors:

Jaeho Kim, Redmond, WA (US);

Joseph L. Sullivan, Kirkland, WA (US);

Robert Marx, Kent, WA (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 1/37 (2006.01); A61N 1/39 (2006.01); A61B 5/0408 (2006.01); A61B 5/0428 (2006.01); A61B 5/0205 (2006.01); A61B 5/00 (2006.01); A61N 1/04 (2006.01);
U.S. Cl.
CPC ...
A61N 1/3904 (2017.08); A61B 5/0205 (2013.01); A61B 5/04085 (2013.01); A61B 5/04288 (2013.01); A61B 5/7221 (2013.01); A61N 1/046 (2013.01); A61N 1/3937 (2013.01); A61N 1/3987 (2013.01);
Abstract

A wearable cardioverter defibrillator system includes a support structure that a patient can wear. The system also includes electrodes that contact the patient, and define two or more channels from which ECG signals are sensed. A processor may evaluate the channels by analyzing their respective ECG signals, to determine which contains less noise than the other(s). The analysis can be by extracting statistics from the ECG signals, optionally after first processing them, and then by comparing these statistics. These statistics may include tall peak counts, amplitudes of peaks compared to historical peak amplitudes, signal baseline shift, dwell time near a baseline, narrow peak counts, zero crossings counts, determined heart rates, and so on. Once the less noisy signal is identified, its channel can be followed preferentially or to the exclusion of other channels, for continuing monitoring and/or determining whether to shock the patient.


Find Patent Forward Citations

Loading…